Frank T Kagawa, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kagawa’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence G53908 · Current
Licensed to practise in California · since 1984 · expires 2028-05-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$8,647
Medicare paid this office $8,647 for 51 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 41 | $5,998 | $73 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $2,168 | $83 |
Who their Medicare patients are
51 Original Medicare patients in 2024. Average age 73 · Women 59% · Also on Medicaid 65% · Health risk score 1.46. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 71% · COPD 39% · Diabetes 33% · Coronary heart disease 22%.
The office billed $77,568, Medicare allowed $12,554 and paid $8,647; for 112 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 51 | 112 | 73 | 1.46 | $77,568 | $8,647 |
| 2023 | 50 | 119 | 72 | 1.17 | $87,910 | $9,161 |
| 2022 | 50 | 125 | 72 | 1.24 | $70,472 | $9,002 |
| 2021 | 53 | 120 | 70 | 1.58 | $58,002 | $9,511 |
| 2020 | 56 | 147 | 70 | 2.03 | $65,627 | $8,657 |
| 2019 | 52 | 150 | 68 | 1.89 | $68,650 | $6,638 |
| 2018 | 50 | 139 | 68 | 1.61 | $80,483 | $7,645 |
| 2017 | 51 | 132 | 69 | 1.50 | $79,185 | $7,652 |
| 2016 | 59 | 166 | 68 | 1.47 | $68,408 | $9,859 |
| 2015 | 86 | 216 | 68 | 1.97 | $70,683 | $14,868 |
| 2014 | 73 | 163 | 67 | 1.63 | $32,524 | $7,521 |
| 2013 | 158 | 221 | 63 | 1.32 | $41,100 | $9,586 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Return visit (30+ min) | 48 | $8,200 | $75 |
2022: 2 services
| Return visit (30+ min) | 44 | $4,767 | $87 |
| Telephone medical discussion with physician, 21-30 minutes | 37 | $3,603 | $66 |
2021: 2 services
| Telephone medical discussion with physician, 21-30 minutes | 45 | $6,731 | $81 |
| Return visit (30+ min) | 15 | $1,883 | $94 |
2020: 2 services
| Telephone medical discussion with physician, 21-30 minutes | 47 | $6,997 | $67 |
| Short return visit (20+ min) | 23 | $756 | $30 |
2019: 2 services
| Short return visit (20+ min) | 49 | $5,688 | $44 |
| Return visit (30+ min) | 13 | $576 | $36 |
2018: 2 services
| Return visit (30+ min) | 39 | $5,919 | $60 |
| Short return visit (20+ min) | 25 | $1,558 | $40 |
2017: 2 services
| Return visit (30+ min) | 46 | $6,737 | $59 |
| Short return visit (20+ min) | 13 | $548 | $42 |
2016: 1 service
| Return visit (30+ min) | 59 | $9,828 | $60 |
2015: 1 service
| Return visit (30+ min) | 76 | $8,834 | $59 |
2014: 3 services
| Short return visit (20+ min) | 51 | $3,507 | $41 |
| Return visit (30+ min) | 25 | $2,517 | $70 |
| New patient visit (30+ min) | 14 | $731 | $52 |
2013: 1 service
| Short return visit (20+ min) | 137 | $6,415 | $34 |
Medicaid work
$1,198 in 2024
Medicaid paid $1,198 for 411 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 200 | $1,198 |
| Medication list documented in medical record (COA) | 118 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 93 | $0 |
| 2024 | 411 | 3 | 24 | $1,198 |
| 2023 | 190 | 1 | 25 | $1,091 |
| 2022 | 83 | 2 | 17 | $408 |
| 2020 | 30 | 1 | 16 | $170 |
| 2019 | 72 | 1 | 18 | $206 |
| 2018 | 147 | 2 | 24 | $591 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 190 | $1,091 |
2022
| Return visit (30+ min) | 70 | $384 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 13 | $24 |
2020
| Short return visit (20+ min) | 30 | $170 |
2019
| Short return visit (20+ min) | 72 | $206 |
2018
| Return visit (30+ min) | 109 | $421 |
| Short return visit (20+ min) | 38 | $170 |
Drugs they prescribed that Part D paid
$227,817
Pharmacies billed $227,817 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 722) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
412 generic and 310 brand-name prescriptions · $227,817 in drug cost · 84 antibiotic prescriptions to 25 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 15 | $56,130 | $3,742 |
| Eliquis | 25 | $19,024 | $761 |
| Atrovent Hfa | 21 | $15,764 | $751 |
| Trelegy Ellipta | 22 | $13,521 | $615 |
| Fluticasone Propionate Hfa | 16 | $7,200 | $450 |
See all 23 drugs
| Dupixent | 15 | $56,130 | $3,742 |
| Eliquis | 25 | $19,024 | $761 |
| Atrovent Hfa | 21 | $15,764 | $751 |
| Trelegy Ellipta | 22 | $13,521 | $615 |
| Fluticasone Propionate Hfa | 16 | $7,200 | $450 |
| Incruse Ellipta | 13 | $6,909 | $531 |
| Ventolin Hfa | 39 | $6,199 | $159 |
| Pulmicort Flexhaler | 11 | $5,446 | $495 |
| Tiotropium | 12 | $4,960 | $413 |
| Advair Hfa | 12 | $4,099 | $342 |
| Arnuity Ellipta | 15 | $3,722 | $248 |
| Albuterol Sulfate Hfa | 67 | $2,900 | $43 |
| Wixela Inhub | 21 | $2,414 | $115 |
| Breyna | 13 | $2,383 | $183 |
| Advair Diskus | 14 | $2,132 | $152 |
| Azithromycin | 52 | $335 | $6 |
| Prednisone | 27 | $319 | $12 |
| Fluticasone Propionate | 42 | $291 | $7 |
| Amoxicillin-Clavulanate Potass | 23 | $186 | $8 |
| Pantoprazole | 16 | $186 | $12 |
| Atorvastatin | 12 | $132 | $11 |
| Montelukast | 15 | $117 | $8 |
| Famotidine | 12 | $112 | $9 |
Year by year
| 2024 | 722 | 52 | 0% (0) | 43% | $227,817 |
| 2023 | 684 | 57 | 2% (11) | None | $177,474 |
| 2022 | 536 | 51 | None | 51% | $120,137 |
| 2021 | 526 | 48 | None | 55% | $119,745 |
| 2020 | 506 | 54 | None | 52% | $121,699 |
| 2019 | 437 | 51 | None | 59% | $128,967 |
| 2018 | 457 | 51 | None | 53% | $125,845 |
| 2017 | 427 | 53 | None | 56% | $86,561 |
| 2016 | 420 | 53 | None | 53% | $94,908 |
| 2015 | 498 | 66 | None | 52% | $90,658 |
| 2014 | 328 | 57 | None | 52% | $56,760 |
| 2013 | 345 | 70 | None | 59% | $64,983 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Dupixent | 11 | $42,627 | $3,875 |
| Eliquis | 19 | $17,201 | $905 |
| Atrovent Hfa | 17 | $16,349 | $962 |
| Flovent Hfa | 29 | $15,357 | $530 |
| Trelegy Ellipta | 20 | $13,058 | $653 |
| Advair Diskus | 25 | $9,406 | $376 |
| Albuterol Sulfate Hfa | 44 | $6,707 | $152 |
| Incruse Ellipta | 13 | $6,526 | $502 |
| Symbicort | 12 | $5,981 | $498 |
| Ventolin Hfa | 52 | $4,680 | $90 |
| Fluticasone-Salmeterol | 11 | $1,520 | $138 |
| Fluticasone Propionate | 56 | $949 | $17 |
| Azithromycin | 44 | $472 | $11 |
| Prednisone | 40 | $374 | $9 |
| Pantoprazole | 16 | $342 | $21 |
| Montelukast | 16 | $313 | $20 |
| Atorvastatin | 14 | $310 | $22 |
| Amoxicillin-Clavulanate Potass | 19 | $297 | $16 |
| Metoprolol | 11 | $207 | $19 |
| Cyclobenzaprine | 14 | $130 | $9 |
2022: 12 drugs
| Atrovent Hfa | 19 | $18,625 | $980 |
| Trelegy Ellipta | 24 | $15,199 | $633 |
| Symbicort | 22 | $11,075 | $503 |
| Flovent Hfa | 23 | $10,426 | $453 |
| Advair Diskus | 25 | $10,182 | $407 |
| Ventolin Hfa | 48 | $5,734 | $119 |
| Albuterol Sulfate Hfa | 49 | $4,156 | $85 |
| Prednisone | 35 | $410 | $12 |
| Fluticasone Propionate | 26 | $354 | $14 |
| Azithromycin | 43 | $276 | $6 |
| Atorvastatin | 14 | $164 | $12 |
| Montelukast | 14 | $123 | $9 |
2021: 13 drugs
| Atrovent Hfa | 28 | $16,564 | $592 |
| Combivent Respimat | 15 | $13,497 | $900 |
| Trelegy Ellipta | 22 | $13,428 | $610 |
| Advair Diskus | 25 | $9,734 | $389 |
| Symbicort | 22 | $9,340 | $425 |
| Ventolin Hfa | 51 | $5,765 | $113 |
| Albuterol Sulfate Hfa | 42 | $4,205 | $100 |
| Pulmicort Flexhaler | 11 | $3,782 | $344 |
| Fluticasone Propionate | 43 | $723 | $17 |
| Prednisone | 30 | $354 | $12 |
| Azithromycin | 28 | $315 | $11 |
| Pantoprazole | 11 | $190 | $17 |
| Atorvastatin | 12 | $155 | $13 |
2020: 13 drugs
| Atrovent Hfa | 23 | $17,645 | $767 |
| Combivent Respimat | 18 | $16,790 | $933 |
| Symbicort | 31 | $15,999 | $516 |
| Spiriva | 26 | $15,828 | $609 |
| Advair Diskus | 29 | $10,827 | $373 |
| Trelegy Ellipta | 14 | $8,162 | $583 |
| Albuterol Sulfate Hfa | 42 | $7,234 | $172 |
| Ventolin Hfa | 33 | $3,179 | $96 |
| Fluticasone Propionate | 42 | $636 | $15 |
| Prednisone | 45 | $574 | $13 |
| Azithromycin | 36 | $354 | $10 |
| Amoxicillin-Clavulanate Potass | 11 | $155 | $14 |
| Trazodone | 11 | $78 | $7 |
2019: 12 drugs
| Symbicort | 40 | $20,921 | $523 |
| Combivent Respimat | 18 | $18,871 | $1,048 |
| Atrovent Hfa | 14 | $16,679 | $1,191 |
| Advair Diskus | 31 | $14,273 | $460 |
| Spiriva | 21 | $13,972 | $665 |
| Spiriva Respimat | 11 | $6,306 | $573 |
| Ventolin Hfa | 36 | $4,975 | $138 |
| Albuterol Sulfate Hfa | 21 | $3,701 | $176 |
| Fluticasone Propionate | 39 | $459 | $12 |
| Prednisone | 26 | $230 | $9 |
| Azithromycin | 24 | $168 | $7 |
| Amoxicillin-Clavulanate Potass | 11 | $111 | $10 |
2018: 14 drugs
| Combivent Respimat | 17 | $16,444 | $967 |
| Symbicort | 32 | $14,662 | $458 |
| Spiriva | 23 | $13,924 | $605 |
| Atrovent Hfa | 14 | $13,252 | $947 |
| Advair Diskus | 21 | $11,687 | $557 |
| Proair Hfa | 31 | $8,367 | $270 |
| Flovent Hfa | 12 | $4,154 | $346 |
| Ventolin Hfa | 38 | $3,799 | $100 |
| Oseltamivir Phosphate | 11 | $1,082 | $98 |
| Fluticasone Propionate | 40 | $413 | $10 |
| Amoxicillin-Clavulanate Potass | 23 | $304 | $13 |
| Montelukast | 19 | $253 | $13 |
| Azithromycin | 30 | $233 | $8 |
| Prednisone | 22 | $207 | $9 |
2017: 11 drugs
| Advair Diskus | 35 | $14,204 | $406 |
| Spiriva | 23 | $12,684 | $551 |
| Atrovent Hfa | 13 | $12,152 | $935 |
| Symbicort | 27 | $11,163 | $413 |
| Combivent Respimat | 12 | $9,378 | $781 |
| Proair Hfa | 29 | $6,389 | $220 |
| Ventolin Hfa | 40 | $3,448 | $86 |
| Fluticasone Propionate | 44 | $452 | $10 |
| Montelukast | 22 | $287 | $13 |
| Prednisone | 27 | $268 | $10 |
| Azithromycin | 22 | $152 | $7 |
2016: 11 drugs
| Advair Diskus | 43 | $21,783 | $507 |
| Spiriva | 24 | $13,636 | $568 |
| Combivent Respimat | 13 | $7,523 | $579 |
| Symbicort | 21 | $6,599 | $314 |
| Proair Hfa | 27 | $6,092 | $226 |
| Ventolin Hfa | 21 | $1,616 | $77 |
| Fluticasone Propionate | 48 | $411 | $9 |
| Montelukast | 32 | $378 | $12 |
| Amoxicillin-Clavulanate Potass | 17 | $361 | $21 |
| Prednisone | 16 | $318 | $20 |
| Azithromycin | 33 | $195 | $6 |
2015: 13 drugs
| Advair Diskus | 45 | $20,183 | $449 |
| Spiriva | 46 | $16,761 | $364 |
| Atrovent Hfa | 11 | $8,676 | $789 |
| Combivent Respimat | 19 | $7,576 | $399 |
| Proair Hfa | 41 | $6,364 | $155 |
| Symbicort | 15 | $4,248 | $283 |
| Qvar | 11 | $1,744 | $159 |
| Fluticasone Propionate | 38 | $565 | $15 |
| Montelukast | 24 | $388 | $16 |
| Amoxicillin-Clavulanate Potass | 20 | $334 | $17 |
| Prednisone | 36 | $327 | $9 |
| Omeprazole | 22 | $305 | $14 |
| Azithromycin | 38 | $295 | $8 |
2014: 11 drugs
| Advair Diskus | 28 | $13,032 | $465 |
| Spiriva | 28 | $12,278 | $438 |
| Atrovent Hfa | 12 | $7,231 | $603 |
| Proair Hfa | 24 | $4,557 | $190 |
| Ventolin Hfa | 18 | $2,605 | $145 |
| Fluticasone Propionate | 28 | $522 | $19 |
| Amox Tr-Potassium Clavulanate | 13 | $279 | $21 |
| Omeprazole | 12 | $223 | $19 |
| Azithromycin | 27 | $208 | $8 |
| Prednisone | 20 | $162 | $8 |
| Fosinopril | 12 | $101 | $8 |
2013: 9 drugs
| Advair Diskus | 41 | $16,376 | $399 |
| Spiriva | 25 | $13,001 | $520 |
| Atrovent Hfa | 17 | $8,958 | $527 |
| Flovent Hfa | 13 | $3,810 | $293 |
| Proair Hfa | 17 | $2,305 | $136 |
| Fluticasone Propionate | 36 | $965 | $27 |
| Azithromycin | 25 | $247 | $10 |
| Fosinopril | 12 | $153 | $13 |
| Furosemide | 16 | $73 | $5 |
Professional record
- NPI
- 1073577623
- Licence
- CA G53908California G53908: Current · expires 2028-05-31
- Trained
- University of California, San Diego School of Medicine, 1983
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G539080
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Internal medicine (207R00000X)
- Mailing address
- 751 S Bascom Ave, San Jose, CA, 95128
- NPI first listed
- 2006-04-12
- NPI last updated
- 2007-08-31
This is when the NPI record was last certified, not a medical board exam.